Clinical Commissioning Policy: Pegvisomant for acromegaly as a third – line treatment (adults)

Document first published:
Page updated:
Topic:
,
Publication type:
This document describes the evidence that has been considered by NHS England in formulating a policy to routinely commission pegvisomant for adult patients with acromegaly.

Document

Clinical Commissioning Policy: Pegvisomant for acromegaly as a third - line treatment (adults)

Clinical Commissioning Policy: Pegvisomant for acromegaly as a third - line treatment (adults)

  • PDF
  • 356 KB
  • 24 pages